From startups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.

An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…


Struggling Ardelyx gets rare trial win for tenapanor

Merck halts Alzheimer’s phase 3 after interim data analysis

AstraZeneca pulls PD-L1 combo test, RSV candidate

Brexit ‘an opportunity,’ but EMA likely to leave London, says AstraZeneca

AstraZeneca CEO: We want a ‘strong, science-led FDA’

Aurinia taps Worldwide Clinical Trials to test lupus candidate in phase 3

Phase 3 hit tees FibroGen, AstraZeneca up for anemia filing

Chutes & Ladders: A new global pharmaceuticals head for GSK

AstraZeneca delays PD-L1 data in rejig of phase 3 program

Chutes & Ladders: John Kapoor retires from troubled Insys